DCF — ADVENTHEALTH ORLANDO
Enterprise Value: $317.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$317.2M
Enterprise Value
$-46.7M
PV of Cash Flows
$363.9M
PV of Terminal Value
$586.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $5.6B | $165.5M | 3.0% | $-76.7M | $-69.7M |
| Year 2 | $5.7B | $227.8M | 4.0% | $-36.0M | $-29.7M |
| Year 3 | $5.9B | $293.6M | 5.0% | $7.2M | $5.4M |
| Year 4 | $6.1B | $332.9M | 5.0% | $30.2M | $20.7M |
| Year 5 | $6.3B | $358.5M | 6.0% | $42.9M | $26.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $317.2M. Terminal value accounts for 115% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$5.4B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.024735977964970585
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5